General: Because congenital insensitivity to pain with anhidrosis (CIPA) is inherited, there is currently no known way to prevent it. Options do exist to prevent injury and infection.
Genetic testing and counseling: Individuals who have CIPA may meet with a genetic counselor to discuss the risks of having children with the disease. Individuals from high-risk populations or those with family histories of CIPA may also meet with a genetic counselor to determine whether they are at risk of having a child with the disease. Carriers can be identified through detailed family histories or genetic testing.
Known carriers of CIPA may undergo genetic counseling before they conceive a child. A genetic counselor can explain the options and the associated risks of various tests, including pre-implantation genetic diagnosis (PGD), amniocentesis, and chorionic villus sampling (CVS).
Pre-implantation genetic diagnosis (PGD) may be used with in vitro (artificial) fertilization. In PGD, embryos are tested for the NTRK1 gene (also called the TRKA gene), and only the embryos that are free of the mutations are implanted. Because CIPA can be detected in an unborn baby, parents may choose whether to continue the pregnancy. A genetic counselor can assist parents with these difficult decisions.
You should read product labels, and discuss all therapies with a qualified healthcare provider. Natural Standard information does not constitute medical advice, diagnosis, or treatment.
For more information visit https://naturalmedicines.therapeuticresearch.com/
Copyright © 2012 by Natural Standard Research Collaboration. All Rights Reserved.